PFIZER HEALTHCARE INDIA PVT LTD

PFIZER HEALTHCARE INDIA PVT LTD is primarily a pharmaceutical manufacturer (factory). It also operates as a trader and distributor for its products within India.

Company Introduction:

PFIZER HEALTHCARE INDIA PVT LTD is the Indian subsidiary of Pfizer Inc., a leading global pharmaceutical and biotechnology corporation headquartered in the United States. The company is a significant player in the Indian healthcare sector, focused on delivering innovative medicines and healthcare solutions to patients across the country.

Its core activities in India include the manufacturing, marketing, and distribution of a wide range of pharmaceutical products, vaccines, and consumer healthcare items. PFIZER HEALTHCARE INDIA PVT LTD’s portfolio spans various therapeutic areas such as oncology, immunology, internal medicine, rare diseases, and anti-infectives, among others. The company maintains manufacturing facilities in India to produce its pharmaceutical formulations and ensures a robust supply chain to make its products accessible throughout the nation. It plays a crucial role in advancing public health and medical science in India through its research, development, and commercialization efforts.

PFIZER HEALTHCARE INDIA PVT LTD manufactures or sells a wide range of pharmaceutical products in India, primarily focusing on prescription medicines and vaccines across various therapeutic areas. Some of their key products include:

Prevenar 13 (Pneumococcal Conjugate Vaccine)

Lipitor (Atorvastatin)

Lyrica (Pregabalin)

Viagra (Sildenafil)

Celebrex (Celecoxib)

Zithromax (Azithromycin)

Diflucan (Fluconazole)

Ibrance (Palbociclib)

Xtandi (Enzalutamide)

Xeljanz (Tofacitinib)

Sutent (Sunitinib)

Vyndaqel (Tafamidis)

Enbrel (Etanercept) - through a distribution agreement

Eliquis (Apixaban) - co-marketed with Bristol-Myers Squibb

Geodon (Ziprasidone)

Spiriva (Tiotropium Bromide) - through a distribution agreement